Meta Study: Targeted Cancer Drugs Yield Fewer Side Effects
By Nuala Moran
Wednesday, August 15, 2012
LONDON A meta-analysis of cancer patients treated in Phase I studies of targeted drugs has confirmed that there is a much lower risk of the most serious side effects than with traditional chemotherapy.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.